ADVERSE REACTIONS
During clinical trials, 550 acne patients were studied. Of these patients, 236 were treated with Benzamycin ® Pak. The most frequently reported adverse event considered at least possibly related was dry skin (7.6%) as compared to Vehicle (3.9%). Application site reactions (stinging, burning sensation, tingling, erythema) were reported in 2.5% of patients versus 1.3% for Vehicle patients. Blepharitis, pruritus and photosensitivity reactions were reported in <2% of patients who used the dual pouch product.
| Treatment Group Summaries
Number of Patients (%)
|
| COSTART Term | Benzamycin® Pak N = 236 | Benzamycin ® Pak Vehicle N = 153 | Benzamycin® Topical Gel N = 121 | Benzamycin® Topical Gel Vehicle N = 40 |
| DRY SKIN | 18 (7.6%) | 6 (3.9%) | 6 (5.0%) | 0 |
APPLICATION SITE REACTION (stinging, erythema, and burning) | 6 (2.5%) | 2 (1.3%) | 1 (0.8%) | 0 |
| BLEPHARITIS | 4 (1.7%) | 1 (0.7%) | 0 | 1 (2.5%) |
| PRURITUS | 4 (1.7%) | 2 (1.3%) | 3 (2.5%) | 0 |
PHOTOSENSITIVITY REACTION (Sunburn, stinging with sun exposure) | 3 (1.3%) | 0 | 0 | 0 |
| PEELING | 1 (0.5%) | 1 (0.7%) | 0 | 0 |
|
REPORTS OF SUSPECTED BENZAMYCIN SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Benzamycin. The information is not vetted and should not be considered as verified clinical evidence.
Possible Benzamycin side effects / adverse reactions in 69 year old female
Reported by a consumer/non-health professional from United States on 2012-03-16
Patient: 69 year old female
Reactions: Rosacea, Erythema, Thermal Burn
Suspect drug(s):
Benzamycin
|